(Q35107627)

6 August 2017

1 reference

title

Plasminogen activation at the cell surface (English)

1 reference

6 August 2017

1 reference

Vincent Ellis

1

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12696753

24 December 2023

publication date

1 January 2003

1 reference

Current Topics in Developmental Biology

6 August 2017

published in

1 reference

6 August 2017

volume

54

1 reference

6 August 2017

page(s)

263-312

1 reference

Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The topology of plasminogen binding and activation on the surface of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-tryp

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Cancer invasion and tissue remodeling--cooperation of protease systems and cell types.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Serine proteases in rodent hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Familial dementia caused by polymerization of mutant neuroserpin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP)

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Cellular strategies for proteolytic targeting during migration and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Binding of disease-associated prion protein to plasminogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue plasminogen activator expression in the embryonic nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Structural relationship between human high and low molecular mass urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Function of the urokinase receptor (CD87) in neutrophil Chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

TATA box-independent transcription of the human tissue plasminogen activator gene initiates within a sequence conserved in related genes

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The species-specific differences in the cAMP regulation of the tissue-type plasminogen activator gene between rat, mouse and human is caused by a one-nucleotide substitution in the cAMP-responsive element of the promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Structural basis of the activation and action of trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The plasminogen activator system: biology and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The role of annexin II tetramer in the activation of plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Sequence determinants of function and evolution in serine proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Regulation of cell survival by secreted proneurotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

PAI-1, fibrosis, and the elusive provisional fibrin matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Functional overlap between two classes of matrix-degrading proteases in wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Plasminogen activator expression in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Characterization of an extremely large, ligand-induced conformational change in plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Induction of plasminogen in rat hippocampal pyramidal neurons by kainic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Role of cell-surface lysines in plasminogen binding to cells: identification of .alpha.-enolase as a candidate plasminogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Mechanisms for pro matrix metalloproteinase activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Multiple instability-regulating sites in the 3' untranslated region of the urokinase-type plasminogen activator mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Kinetic analysis of the interaction between vitronectin and the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Making tissue-type plasminogen activator more fibrin specific

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Genome evolution and the evolution of exon-shuffling--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Impaired wound healing in mice with a disrupted plasminogen gene

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Extracellular proteolysis in the adult murine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Integrin signaling revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Lipid rafts and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Fibrin as a factor in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Heparin binding to the urokinase kringle domain

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue plasminogen activator as a key effector in neurobiology and neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The PAN module: the N-terminal domains of plasminogen and hepatocyte growth factor are homologous with the apple domains of the prekallikrein family and with a novel domain found in numerous nematode proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Amiloride selectively inhibits the urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

ECM and cell surface proteolysis: regulating cellular ecology

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Tissue plasminogen activator binds to human vascular smooth muscle cells by a novel mechanism. Evidence for a reciprocal linkage between inhibition of catalytic activity and cellular binding

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Localization of urokinase to focal adhesions by human fibrosarcoma cells synthesizing recombinant vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2803%2954012-1

7 January 2021

Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver

7

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator

24 December 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer

24 December 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Prevention of metastasis by inhibition of the urokinase receptor

24 December 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Plasminogen Activation by Receptor-Bound Urokinase

24 December 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Tissue cooperation in a proteolytic cascade activating human interstitial collagenase

24 December 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways

24 December 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane

24 December 2023

104

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice

24 December 2023

129

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor

24 December 2023

131

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells

24 December 2023

133

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma

24 December 2023

158

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

24 December 2023

159

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene

24 December 2023

170

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase

24 December 2023

180

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes

24 December 2023

188

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin

24 December 2023

195

1 reference

https://api.crossref.org/works/10.1016/S0070-2153(03)54012-1

24 December 2023

Identifiers

1 reference

6 August 2017

1 reference